variant

Hemex Health Receives FDA Breakthrough Device Designation for Gazelle Hb Variant Test

PORTLAND, Ore., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Hemex Health, a medical diagnostics company focused on decentralized testing for blood-based…

3 weeks ago

Invivyd Announces Continued Neutralizing Activity of PEMGARDA (pemivibart) and VYD2311 Against Currently Dominant SARS-CoV-2 Variant XFG (Stratus)

August 18, 2025 16:32 ET  | Source: Invivyd New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDA® (pemivibart)…

6 months ago